- A study from the State Key Laboratory of Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; University of Chinese Academy of Sciences, Beijing 100049, China etc., has reported that “Atg7 is required for acrosome biogenesis during spermatogenesis in mice.”
- This study was published in the 23 May 2014 Cell Reports by Prof. Li W and Wang H, and others from the State Key Laboratory of Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; University of Chinese Academy of Sciences, Beijing 100049, China etc..
- On the foundation of this interesting finding, Dr L Boominathan, Director-cum-chief Scientist of GBMD, reports here that: Mechanistic and Therapeutic insights into the treatment of Globozoospermia: MiRNA-17 regulates Acrosome biogenesis during Spermatogenesis via down regulation of its target gene. This study suggests that MiRNA-17, by decreasing the expression of its target gene, it could regulate Acrosome biogenesis during Spermatogenesis. Taken together, this study suggests that pharmacological formulations containing “MiRNA-17 regulator” can be used to treat Globozoospermia.
Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Web: http://genomediscovery.org
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
To cite: Boominathan, Mechanistic and Therapeutic insights into the treatment of Globozoospermia: MiRNA-17 regulates Acrosome biogenesis during Spermatogenesis via down regulation of its target gene, 13/July/2014, 6.50 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
* Research cooperation